Telnife 40 Tablet
Marketer
Dwivsonchem Life Science
Salt Composition
Telmisartan (40mg)
Overview Telnife 40 Tablet
Cardiopress 40mg tablets manage hypertension and congestive heart failure. Reduced blood pressure mitigates the risk of stroke and myocardial infarction. This medication also protects renal function in diabetic patients. Cardiopress 40mg may be used independently or in conjunction with other therapies. It can be administered with or without food, at any time of day, but consistency is key for optimal results. Continued use is crucial, even with controlled blood pressure or feeling well; discontinuation may worsen the condition. This widely prescribed medication boasts a strong safety profile for extended use. Lifestyle modifications, such as increased physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as advised), further support blood pressure control. Generally well-tolerated, potential side effects like hypotension may occur. Report any adverse effects; dosage adjustment or alternative medication may be considered. Prior to commencing treatment, disclose any hepatic or renal issues. Pregnant or lactating individuals should seek medical counsel. Routine monitoring of kidney function, blood pressure, and serum potassium levels may be undertaken during treatment.
Uses of Telnife 40 Tablet
Managing high blood pressure and heart failure | Reducing fever | Cardiovascular event prevention
Major Benefits of Telnife 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telnife 40 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
Common Side effects of Telnife 40 Tablet:
- Diarrhea
- Upper respiratory tract infection
- Back pain
- Sinus inflammation
- Skin ulcer
- Intermittent claudication
How to use Telnife 40 Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telnife 40 Tablet can be administered with or without food, although consistent timing is recommended.
How Telnife 40 Tablet works:
Telnife 40mg tablets contain an angiotensin receptor blocker, or ARB. This medication works by inhibiting a substance that constricts blood vessels, thus promoting vasodilation. Consequently, blood pressure decreases, improving blood flow throughout the body and reducing the workload on the heart.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telnife 40 Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Telnife 40 Tablet during pregnancy poses a confirmed risk to the fetus. Therefore, it's not recommended. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Telnife 40 Tablet with breastfeeding are lacking. Seek medical advice.
DrivingUNSAFE
Taking Telnife 40 mg tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
For individuals with severe kidney impairment, Telnife 40 Tablet requires careful administration. Dosage modification of Telnife 40 Tablet might be necessary. Physician consultation is recommended. Pre-existing kidney disease should be disclosed to your doctor. Routine monitoring of blood pressure, creatinine, and potassium levels may be suggested during treatment.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Telnife 40 Tablet, potentially requiring dosage modification under medical supervision. Telnife 40 Tablet is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Telnife 40 Tablet :
Omit any missed Telnife 40 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Telnife 40 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |



